A rheumatologist discusses how her understanding of chronic pain in PsA has evolved—and how it affects her approach to ...

Fentanyl is a wonder drug. Not only is it useful for managing severe pain (e.g., for cancer patients and burn victims) but it ...

April 11-17th is Black Maternal Health Week, and this year’s theme emphasizes the power of Black-led perinatal, maternal, and ...

Including a curl-defining cream, a Korean glow serum, a cuticle oil, and more products that'll help keep your hair, skin and ...

No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

Join Marla Littlejohn and Dr. Gigi for a compelling conversation on dermatology, enriched by Marla's personal experience with psoriasis.

The AHA has published a scientific statement regarding disparities in current pulmonary embolism management and outcomes.

In the Black community, the quote “Black people don’t need sunscreen” because of its natural protection, but the truth is, UV ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

From skin cancer to vitiligo, learn about five important skin conditions affecting darker skin tones and how to properly ...

LaShell Robinson, head of global feasibility and trial equity at Takeda, identifies some of the key barriers in achieving ...

LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses strategies to address underrepresentation in clinical trials, particularly in phase III psoriasis trials.